Nox Medical, the medical device business unit of Nox Health, announced its receipt of patents from the United States Patent and Trademark Office (USPTO) and the European Patent Office (EPO) related to the Nox RIP [respiratory inductance plethysmography] belts, which are incorporated into all of Nox Medical’s diagnostic sleep tests. […]
Tag: PSG
Case Study: Integrating OAT in Atrial Fibrillation Management for OSA Patients
As the prevalence of atrial fibrillation (AF) continues to rise, particularly among the aging population, its connection with obstructive sleep apnea (OSA) has become increasingly evident.1 Patients with AF seeking treatment for OSA often present with a complex medical history that includes a number of comorbidities, such as hypertension, acid […]
Onera Launches Medical Advisory Board to Support Company Growth
Onera Health, a leader in transforming sleep medicine and remote monitoring, today announced the formation of a Medical Advisory Board to continue delivering on its commitment to making clinical-grade remote diagnostics and monitoring broadly accessible and user-friendly. The Medical Advisory Board consists of Prof. Dr. Ludger Grote (Gothenburg), Prof. Dr. […]
Onera STS HSAT & In-Lab System Granted FDA Approval
Onera Health announced that its wholly owned subsidiary in the Netherlands, Onera B.V., has received 510(k) market clearance from the U.S. Food & Drug Administration (FDA) for its ground-breaking system for Polysomnography (PSG) studies, Onera STS, paving the way for widespread deployment of the patch-based technology across healthcare systems in […]
Sleep Disruption Can Vary Depending on the Respiratory Event Type and Severity in OSA
The quality of sleep, e.g., sleep stages and arousals from sleep, can be assessed based on the electroencephalogram (EEG) signal recorded during a polysomnogram. Even though arousals from sleep are identified from overnight recordings to characterize the degree of sleep interruption, this information is seldom utilized when assessing OSA severity. […]
OSA Common in Primary Sjögren’s Syndrome, Turkish Study Shows
Obstructive sleep apnea (OSA) is common among people with primary Sjögren’s syndrome, a study found. Sjögren’s syndrome is a chronic autoimmune disorder that primarily affects the glands producing tears and saliva, leading to symptoms of dryness in the eyes and mouth, but also can affect multiple other tissues. Since OSA is […]
Nox Medical Introduces Nox A1s PSG System
Nox Medical, the sleep technology arm of Nox Health, has released the Nox A1s PSG system which features hospital-to-home flexibility and product enhancements to its predecessor, Nox A1. The Nox A1s is a future-proof investment with telehealth capabilities to perform in-lab and at-home sleep testing, making it one of the […]
Nox Medical Virtual Product Launch
Nox Medical Virtual Product Launch Thursday, October 7th, 2021 8:00am PT / 11:00am ET / 17:00pm CEST In a time where we are seeing growth in awareness of sleep health and the demand for sleep studies continues to expand, polysomnography remains the gold standard for sleep studies. But not all […]
Onera Gets More Funding for PSG Quality Home Device
Onera Health closed the Series B funding round today, bringing the total funding raised to date above the €24M mark. Led by Innovation Industries in close collaboration with Invest-NL and with existing investors Jazz Pharmaceuticals, imec.xpand, BOM, and 15th Rock, the company intends to use the funds to execute clinical […]
Cadwell Partners with EnsoData for Sleep AI
Cadwell Industries, Inc announces a partnership with EnsoData, a healthcare artificial intelligence (AI) company dedicated to improving the lives of medical professionals and their patients. Cadwell is the first sleep diagnostic equipment provider to more deeply integrate EnsoData’s EnsoSleep AI scoring solution by modifying its Easy III PSG software platform. This […]